2784 — Alfresa Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapContrarian

Annual income statement for Alfresa Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064
Cost of Revenue
Gross Profit	187,469	192,086	206,372	213,928	217,881
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,559,998	2,669,553	2,822,003	2,930,218	3,069,788
Operating Profit	25,645	26,516	36,497	30,833	34,276
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	48,180	38,591	43,795	39,359	62,007
Provision for Income Taxes
Net Income After Taxes	32,203	25,789	29,574	27,436	41,832
Minority Interest
Net Income Before Extraordinary Items
Net Income	32,183	25,787	29,559	27,390	41,747
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	32,182	25,786	29,558	27,389	41,746
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	167	142	163	177	239
Dividends per Share
Special Dividends per Share